ESR1 and breast carcinoma: They found that Gly brought about up to 50% of the estrogenic response and induced breast cancer cell proliferation, as well as the expression of both ERs after 6 h and of only ERα after 24 h of exposure; however, in the presence of endogenous estrogen, this compound acted as an antagonist.